200 related articles for article (PubMed ID: 35298541)
1. Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach.
Salaria D; Rolta R; Mehta J; Awofisayo O; Fadare OA; Kaur B; Kumar B; Araujo da Costa R; Chandel SR; Kaushik N; Choi EH; Kaushik NK
PLoS One; 2022; 17(3):e0265420. PubMed ID: 35298541
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel inhibitor phytoconstituents for Influenza A H3N2: an
Rolta R; Salaria D; Fadare OA; Fadare RY; Masih GD; Prakash A; Medhi B
J Biomol Struct Dyn; 2024 Jan; ():1-10. PubMed ID: 38247233
[TBL] [Abstract][Full Text] [Related]
3. An
Kaur B; Rolta R; Salaria D; Kumar B; Fadare OA; da Costa RA; Ahmad A; Al-Rawi MBA; Raish M; Rather IA
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807321
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial potential of phytocompounds of
Shalini K; Guleria S; Salaria D; Rolta R; Fadare OA; Mehta J; Awofisayo O; Mandyal P; Shandilya P; Kaushik N; Choi EH; Chandel SR; Kaushik NK
J Biomol Struct Dyn; 2024 Mar; 42(5):2726-2737. PubMed ID: 37177811
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus (HPV) Entry Inhibitors.
Zhu Y
Adv Exp Med Biol; 2022; 1366():223-239. PubMed ID: 35412144
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy.
Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN
Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657
[TBL] [Abstract][Full Text] [Related]
8. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
9. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
[TBL] [Abstract][Full Text] [Related]
10. Age-specific prevalence and genotype distribution of human papillomavirus in women from Northwest China.
Lin X; Chen L; Zheng Y; Yan F; Li J; Zhang J; Yang H
Cancer Med; 2022 Nov; 11(22):4366-4373. PubMed ID: 35365956
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking studies of phytocompounds of
Rolta R; Salaria D; Kumar V; Patel CN; Sourirajan A; Baumler DJ; Dev K
J Biomol Struct Dyn; 2022 May; 40(8):3789-3803. PubMed ID: 33225862
[No Abstract] [Full Text] [Related]
12. Antibacterial Potential of
Mehta J; Utkarsh K; Fuloria S; Singh T; Sekar M; Salaria D; Rolta R; Begum MY; Gan SH; Rani NNIM; Chidambaram K; Subramaniyan V; Sathasivam KV; Lum PT; Uthirapathy S; Fadare OA; Awofisayo O; Fuloria NK
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956923
[TBL] [Abstract][Full Text] [Related]
13. Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study.
Arroyo Mühr LS; Eklund C; Lagheden C; Forslund O; Robertsson KD; Dillner J
J Clin Virol; 2022 Sep; 154():105237. PubMed ID: 35820294
[TBL] [Abstract][Full Text] [Related]
14. Identification of HPV16's E6 gene in suspected cases of cervical lesions and docking Study of its L1 protein with active components of
Lukman Y; Bala DA; Malik KI; Saidu A; Saleh KA; Abubakar BJ; Abubakar AI
Afr Health Sci; 2022 Mar; 22(1):98-105. PubMed ID: 36032471
[TBL] [Abstract][Full Text] [Related]
15. Ethnographic study of the barriers and facilitators to implementing human papillomavirus (HPV) self-sampling as a primary screening strategy for cervical cancer among Inuit women of Nunavik, Northern Quebec.
Gamelin R; Hébert M; Tratt E; Brassard P
Int J Circumpolar Health; 2022 Dec; 81(1):2032930. PubMed ID: 35166191
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario.
Lee GY; Inthasorn P; Laowahutanont P; Lawpoolsri S; Kamolratanakul S; Lungchukiet P; Oh J; Termrungruanglert W; Taechakraichana N; Pitisuttithum P
Vaccine; 2022 Mar; 40(13):1968-1976. PubMed ID: 35190207
[TBL] [Abstract][Full Text] [Related]
18. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus sequencing reveals its usefulness for the management of HIV-infected women at risk for developing cervical cancer.
Piyathilake CJ; Kumar R; Crowley MR; Badiga S; Burkholder GA
J Obstet Gynaecol Res; 2021 Jun; 47(6):2185-2195. PubMed ID: 33754434
[TBL] [Abstract][Full Text] [Related]
20. Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer.
Burger EA; Kim JJ; Sy S; Castle PE
Clin Infect Dis; 2017 Sep; 65(6):893-899. PubMed ID: 28531261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
